In another study, Kahara et al., analyzed by immunohistochemistry the expression of several CD44 isoforms in a series of 47 sarcomas (18 malignant fibrous histiocytomas, 13 synovial sarcomas, 7 malignant schwannomas, and 9 liposarcomas). This evidence concerns the gene CD44 and sarcoma.